A Study of Lebrikizumab in Adults With Nummular Eczema

计划入组 270 人 · 首次发布于 2026 年 4 月 21 日

Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema

计划入组 70 人 · 首次发布于 2020 年 10 月 23 日

An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema

计划入组 31 人 · 首次发布于 2017 年 5 月 19 日

Chronic Hand Eczema(Alys)

Difluocortolone

C₂₂H₂₈F₂O₄

Clobetasone

C₂₂H₂₆ClFO₄

BHC COSMEDICAL PTY LTD

Australia

Hoth Therapeutics

United States

Zelira Therapeutics Ltd

Almirall Launches Phase III Trial Testing Lebrikizumab for Nummular Eczema Treatment

Elimination Diets Offer Limited Relief for Childhood Eczema, Study Suggests

FDA Approves Eli Lilly's Eczema Drug